HEADER TRANSFERASE/INHIBITOR 20-FEB-13 3ZO2 TITLE THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE TITLE 2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 9 CHAIN: I; COMPND 10 FRAGMENT: RESIDUES 6-25; COMPND 11 SYNONYM: PKI-ALPHA; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 11 ORGANISM_COMMON: BOVINE; SOURCE 12 ORGANISM_TAXID: 9913 KEYWDS TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.E.ALLEN,C.L.CHOW,J.J.CALDWELL,I.M.WESTWOOD,R.L.VAN MONTFORT, AUTHOR 2 I.COLLINS REVDAT 6 20-DEC-23 3ZO2 1 REMARK LINK REVDAT 5 03-APR-19 3ZO2 1 REMARK LINK REVDAT 4 28-MAR-18 3ZO2 1 JRNL REVDAT 3 04-SEP-13 3ZO2 1 JRNL REVDAT 2 21-AUG-13 3ZO2 1 JRNL REVDAT 1 06-MAR-13 3ZO2 0 JRNL AUTH C.E.ALLEN,C.L.CHOW,J.J.CALDWELL,I.M.WESTWOOD, JRNL AUTH 2 R.L.VAN MONTFORT,I.COLLINS JRNL TITL SYNTHESIS AND EVALUATION OF HETEROARYL SUBSTITUTED JRNL TITL 2 DIAZASPIROCYCLES AS SCAFFOLDS TO PROBE THE ATP-BINDING SITE JRNL TITL 3 OF PROTEIN KINASES. JRNL REF BIOORG. MED. CHEM. V. 21 5707 2013 JRNL REFN ESSN 1464-3391 JRNL PMID 23920481 JRNL DOI 10.1016/J.BMC.2013.07.021 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 31513 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.191 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1588 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.04 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.68 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2854 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1704 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2705 REMARK 3 BIN R VALUE (WORKING SET) : 0.1683 REMARK 3 BIN FREE R VALUE : 0.2089 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 149 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2916 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.43500 REMARK 3 B22 (A**2) : -1.35360 REMARK 3 B33 (A**2) : 2.78860 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.148 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.130 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.134 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.124 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3057 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4149 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1055 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 73 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 457 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3057 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 385 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3932 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.95 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.22 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.20 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -27.3676 -1.8840 2.6951 REMARK 3 T TENSOR REMARK 3 T11: -0.0894 T22: -0.0693 REMARK 3 T33: -0.0907 T12: 0.0109 REMARK 3 T13: -0.0027 T23: -0.0135 REMARK 3 L TENSOR REMARK 3 L11: 0.7595 L22: 1.0508 REMARK 3 L33: 1.3583 L12: 0.1926 REMARK 3 L13: -0.0098 L23: -0.3226 REMARK 3 S TENSOR REMARK 3 S11: -0.0158 S12: 0.0080 S13: 0.0409 REMARK 3 S21: 0.0024 S22: 0.0110 S23: 0.0639 REMARK 3 S31: -0.1649 S32: -0.0878 S33: 0.0047 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN I REMARK 3 ORIGIN FOR THE GROUP (A): -14.0002 1.7622 -10.6607 REMARK 3 T TENSOR REMARK 3 T11: 0.0228 T22: 0.0129 REMARK 3 T33: -0.0291 T12: -0.0213 REMARK 3 T13: 0.0095 T23: -0.0034 REMARK 3 L TENSOR REMARK 3 L11: 0.7821 L22: 1.3721 REMARK 3 L33: 3.5897 L12: -0.4828 REMARK 3 L13: -0.4380 L23: -0.3456 REMARK 3 S TENSOR REMARK 3 S11: -0.0092 S12: 0.0718 S13: -0.0976 REMARK 3 S21: 0.0781 S22: -0.0340 S23: 0.0397 REMARK 3 S31: 0.1209 S32: 0.0503 S33: 0.0432 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ZO2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1290055877. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97630 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31616 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 55.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2GFC REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25MM MES-BISTRIS PH6.5, 75MM LICL, 1MM REMARK 280 DTT, 0.1MM EDTA, 1.5MM MEGA8; 4 DEGREE CELSIUS, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.42500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.18500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.86000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.18500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.42500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.86000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 HIS I 23 REMARK 465 ASP I 24 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 7 CG CD CE NZ REMARK 470 LYS A 8 CG CD CE NZ REMARK 470 GLU A 11 CG CD OE1 OE2 REMARK 470 GLN A 12 CG CD OE1 NE2 REMARK 470 LYS A 16 CD CE NZ REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 LYS A 21 CD CE NZ REMARK 470 GLU A 24 CD OE1 OE2 REMARK 470 LYS A 61 CE NZ REMARK 470 LYS A 83 CE NZ REMARK 470 LYS A 105 CD CE NZ REMARK 470 ILE A 135 CD1 REMARK 470 LYS A 213 CD CE NZ REMARK 470 LYS A 254 CD CE NZ REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 295 CD CE NZ REMARK 470 GLU A 311 CB CG CD OE1 OE2 REMARK 470 LYS A 317 CD CE NZ REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 319 CG CD CE NZ REMARK 470 LYS A 345 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 166 39.02 -140.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2391 DISTANCE = 5.90 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15I A 1351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1352 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 1354 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ZO1 RELATED DB: PDB REMARK 900 THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZO3 RELATED DB: PDB REMARK 900 THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZO4 RELATED DB: PDB REMARK 900 THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE REMARK 900 INHIBITORS DBREF 3ZO2 A 0 350 UNP P00517 KAPCA_BOVIN 1 351 DBREF 3ZO2 I 5 24 UNP P63248 IPKA_MOUSE 6 25 SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN SEQRES 15 A 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 3ZO2 SEP A 10 SER PHOSPHOSERINE MODRES 3ZO2 SEP A 139 SER PHOSPHOSERINE MODRES 3ZO2 TPO A 197 THR PHOSPHOTHREONINE MODRES 3ZO2 SEP A 338 SER PHOSPHOSERINE HET SEP A 10 10 HET SEP A 139 10 HET TPO A 197 11 HET SEP A 338 10 HET 15I A1351 20 HET GOL A1352 6 HET GOL A1353 6 HET MPD A1354 8 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM 15I 6-(2,9-DIAZASPIRO[5.5]UNDECAN-9-YL)-9H-PURINE HETNAM GOL GLYCEROL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 15I C14 H20 N6 FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 MPD C6 H14 O2 FORMUL 7 HOH *420(H2 O) HELIX 1 1 GLY A 9 ASN A 32 1 24 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SEP A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 SER A 252 1 11 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 THR I 5 SER I 13 1 9 SHEET 1 AA 5 PHE A 43 GLY A 52 0 SHEET 2 AA 5 GLY A 55 HIS A 62 -1 O GLY A 55 N GLY A 52 SHEET 3 AA 5 HIS A 68 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 AA 5 ASN A 115 GLU A 121 -1 O LEU A 116 N LEU A 74 SHEET 5 AA 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AB 2 LEU A 162 ILE A 163 0 SHEET 2 AB 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AC 2 LEU A 172 ILE A 174 0 SHEET 2 AC 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C GLY A 9 N SEP A 10 1555 1555 1.35 LINK C SEP A 10 N GLU A 11 1555 1555 1.35 LINK C PHE A 138 N SEP A 139 1555 1555 1.35 LINK C SEP A 139 N GLU A 140 1555 1555 1.34 LINK C TRP A 196 N TPO A 197 1555 1555 1.35 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.34 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 SITE 1 AC1 12 LEU A 49 VAL A 57 ALA A 70 GLU A 121 SITE 2 AC1 12 VAL A 123 GLU A 127 GLU A 170 ASN A 171 SITE 3 AC1 12 LEU A 173 ASP A 184 PHE A 327 HOH A2193 SITE 1 AC2 6 VAL A 15 PHE A 18 LEU A 152 GLU A 155 SITE 2 AC2 6 GOL A1353 HOH A2336 SITE 1 AC3 5 PHE A 18 GLN A 307 GOL A1352 HOH A2346 SITE 2 AC3 5 HOH A2347 SITE 1 AC4 4 HIS A 131 ASN A 326 PHE A 327 ASP A 328 CRYST1 72.850 75.720 80.370 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013727 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013207 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012442 0.00000